Schedule
-
The Criminal Code
Section
3
CHAPTER 9
-
DANGERS TO THE COMMUNITY
Part 9.1
-
Serious drug offences
History
Pt 9.1 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
Division 301
-
Serious drugs and precursors
History
Div 301 substituted by No 167 of 2012, s 3 and Sch 1 item 16, applicable in relation to offences against Part
9.1
of the
Criminal Code
that are committed on or after 29 May 2013. No 167 of 2012, s 3 and Sch 1 item 24 contains the following transitional provisions:
24 Transitional
-
listing of existing serious drugs and precursors by regulation
(1)
This item applies in relation to a substance or plant that, immediately before the commencement of this item, was listed under Division 314 of the
Criminal Code
as belonging to any of the following classes of substances or plants (the substance
'
s or plant
'
s
Criminal Code class
):
(a)
a controlled drug;
(b)
a controlled plant;
(c)
a controlled precursor;
(d)
a border controlled drug;
(e)
a border controlled plant;
(f)
a border controlled precursor.
(2)
Sections 301.7 and 301.8 of the
Criminal Code
, as amended by Part 1 of this Schedule, do not apply in relation to a regulation made for the purposes of Subdivision A of Division 301 of the
Criminal Code
(as so amended) listing the substance or plant as belonging to the same Criminal Code class as that to which it belonged immediately before the commencement of this item.
Note 1:
Sections 301.7 and 301.8 of the
Criminal Code
, as so amended, provide that some conditions must be satisfied before new regulations can be made listing a substance or plant as belonging to a Criminal Code class.
Note 2:
For the commencement of this item, see section 2 of this Act.
Div 301 formerly read:
Division 301
-
Listing additional drugs, plants and precursors
Subdivision A
-
Interim regulations
History
Subdiv 301 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 301.1 Interim regulations
-
controlled drugs and controlled plants
(1)
The regulations may prescribe:
(a)
a substance, other than a growing plant, as a controlled drug; or
(b)
a growing plant as a controlled plant;
if the conditions set out in subsection (2) are met.
(2)
The conditions are as follows:
(a)
the Minister must be satisfied that taking the substance or plant concerned:
(i)
would create a substantial risk of death or serious harm; or
(ii)
would have a physical or mental effect substantially similar to that caused by taking a substance or plant already listed or described in section
314.1
or
314.2
;
(b)
the Minister must be satisfied that there is a substantial risk that the substance or plant will be taken without appropriate medical supervision.
(3)
However, the regulations must not prescribe a particular substance or plant under this section for a period that exceeds, or for periods that in total exceed, 12 months.
History
S 301.1 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 301.2 Interim regulations
-
controlled precursors
(1)
The regulations may prescribe a substance (including a growing plant) as a controlled precursor if the condition set out in subsection (2) is met.
(2)
The condition is that the Minister must be satisfied that there is a substantial risk that the substance concerned will be used to unlawfully manufacture a controlled drug.
(3)
However, the regulations must not prescribe a particular substance under this section for a period that exceeds, or for periods that in total exceed, 12 months.
History
S 301.2 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 301.3 Interim regulations
-
border controlled drugs and border controlled plants
(1)
The regulations may prescribe:
(a)
a substance, other than a growing plant, as a border controlled drug; or
(b)
a growing plant as a border controlled plant;
if the conditions set out in subsection (2) are met.
(2)
The conditions are as follows:
(a)
the Minister must be satisfied that taking the substance or plant concerned:
(i)
would create a substantial risk of death or serious harm; or
(ii)
would have a physical or mental effect substantially similar to that caused by taking a substance or plant already listed or described in section
314.4
or
314.5
;
(b)
the Minister must be satisfied that there is a substantial risk that the substance or plant will be taken without appropriate medical supervision.
(3)
However, the regulations must not prescribe a particular substance or plant under this section for a period that exceeds, or for periods that in total exceed, 12 months.
History
S 301.3 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 301.4 Interim regulations
-
border controlled precursors
(1)
The regulations may prescribe a substance (including a growing plant) as a border controlled precursor if the condition set out in subsection (2) is met.
(2)
The condition is that the Minister must be satisfied that there is a substantial risk that the substance concerned will be used to unlawfully manufacture a controlled drug.
(3)
However, the regulations must not prescribe a particular substance under this section for a period that exceeds, or for periods that in total exceed, 12 months.
History
S 301.4 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 301.5 Interim regulations
-
commercial, marketable and trafficable quantities
(1)
The regulations may prescribe:
(a)
a quantity of a controlled drug or controlled plant as a commercial, marketable or trafficable quantity of the drug or plant; or
(b)
a quantity of a controlled precursor as a commercial or marketable quantity of the precursor.
(2)
However, the regulations must not prescribe:
(a)
a commercial quantity of a particular controlled drug, controlled plant or controlled precursor; or
(b)
a marketable quantity of a particular controlled drug, controlled plant or controlled precursor; or
(c)
a trafficable quantity of a particular controlled drug or controlled plant;
for a period that exceeds, or for periods that in total exceed, 12 months.
(3)
If:
(a)
there is no commercial, marketable or trafficable quantity specified in section
314.1
for a substance listed or described as a controlled drug in that section; or
(b)
there is no commercial, marketable or trafficable quantity specified in section
314.2
for a substance listed or described as a controlled plant in that section; or
(c)
there is no commercial or marketable quantity specified in section
314.3
for a substance listed or described as a controlled precursor in that section;
regulations under subsection (1) may prescribe such a quantity of the drug, plant or precursor.
(4)
The regulations may prescribe a quantity of a border controlled drug, border controlled plant or border controlled precursor as a commercial or marketable quantity of the drug, plant or precursor.
(5)
However, the regulations must not prescribe:
(a)
a commercial quantity of a particular border controlled drug, border controlled plant or border controlled precursor; or
(b)
a marketable quantity of a particular border controlled drug, border controlled plant or border controlled precursor;
for a period that exceeds, or for periods that in total exceed, 12 months.
(6)
If:
(a)
there is no commercial or marketable quantity specified in section
314.4
for a substance listed or described as a border controlled drug in that section; or
(b)
there is no commercial or marketable quantity specified in section
314.5
for a substance listed or described as a border controlled plant in that section; or
(c)
there is no commercial or marketable quantity specified in section
314.6
for a substance listed or described as a border controlled precursor in that section;
regulations under subsection (4) may prescribe such a quantity of the drug, plant or precursor.
History
S 301.5 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
Subdivision B
-
Emergency determinations
History
Subdiv B inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 301.6 Emergency determinations
-
controlled drugs and controlled plants
(1)
The Minister may, by legislative instrument, determine that:
(a)
a substance, other than a growing plant, is a controlled drug; or
(b)
a growing plant is a controlled plant.
(2)
The Minister must not make a determination under subsection (1) unless he or she is satisfied:
(a)
that taking the substance or plant concerned:
(i)
would create a substantial risk of death or serious harm; or
(ii)
would have a physical or mental effect substantially similar to that caused by taking a substance or plant already listed or described in section
314.1
or
314.2
; and
(b)
that there is an imminent and substantial risk that the substance or plant will be:
(i)
taken without appropriate medical supervision; or
(ii)
imported and made available for taking without appropriate medical supervision.
Note:
Sections
301.11
and
301.12
set out general rules for emergency determinations.
History
S 301.6 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 301.7 Emergency determinations
-
controlled precursors
(1)
The Minister may, by legislative instrument, determine that a substance (including a growing plant) is a controlled precursor.
(2)
The Minister must not make a determination under subsection (1) unless he or she is satisfied that there is an imminent and substantial risk that the substance will be:
(a)
used to unlawfully manufacture a controlled drug; or
(b)
imported and made available to be used in unlawfully manufacturing a controlled drug.
Note:
Sections
301.11
and
301.12
set out general rules for emergency determinations.
History
S 301.7 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005
SECTION 301.8 Emergency determinations
-
border controlled drugs and border controlled plants
(1)
The Minister may, by legislative instrument, determine that:
(a)
a substance, other than a growing plant, is a border controlled drug; or
(b)
a growing plant is a border controlled plant.
(2)
The Minister must not make a determination under subsection (1) unless he or she is satisfied:
(a)
that taking the substance or plant concerned:
(i)
would create a substantial risk of death or serious harm; or
(ii)
would have a physical or mental effect substantially similar to that caused by taking a substance or plant already listed or described in section
314.4
or
314.5
; and
(b)
that there is an imminent and substantial risk that the substance or plant will be:
(i)
taken without appropriate medical supervision; or
(ii)
imported and made available for taking without appropriate medical supervision.
Note:
Sections
301.11
and
301.12
set out general rules for emergency determinations.
History
S 301.8 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 301.9 Emergency determinations
-
border controlled precursors
(1)
The Minister may, by legislative instrument, determine that a substance (including a growing plant) is a border controlled precursor.
(2)
The Minister must not make a determination under subsection (1) unless he or she is satisfied that there is an imminent and substantial risk that the substance will be:
(a)
used to unlawfully manufacture a controlled drug; or
(b)
imported and made available to be used in unlawfully manufacturing a controlled drug.
Note:
Sections
301.11
and
301.12
set out general rules for emergency determinations.
History
S 301.9 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 301.10 Emergency determinations
-
commercial, marketable and trafficable quantities
(1)
The Minister may, by legislative instrument, determine that:
(a)
a quantity of a controlled drug or controlled plant is a commercial, marketable or trafficable quantity of the drug or plant; or
(b)
a quantity of a controlled precursor is a commercial or marketable quantity of the precursor.
(2)
If:
(a)
there is no commercial, marketable or trafficable quantity specified in section
314.1
for a substance listed or described as a controlled drug in that section; or
(b)
there is no commercial, marketable or trafficable quantity specified in section
314.2
for a substance listed or described as a controlled plant in that section; or
(c)
there is no commercial or marketable quantity specified in section
314.3
for a substance listed or described as a controlled precursor in that section;
the Minister may, under subsection (1), determine such a quantity of the drug, plant or precursor.
(3)
The Minister may, by legislative instrument, determine that a quantity of a border controlled drug, border controlled plant or border controlled precursor is a commercial or marketable quantity of the drug, plant or precursor.
(4)
If:
(a)
there is no commercial or marketable quantity specified in section
314.4
for a substance listed or described as a border controlled drug in that section; or
(b)
there is no commercial or marketable quantity specified in section
314.5
for a substance listed or described as a border controlled plant in that section; or
(c)
there is no commercial or marketable quantity specified in section
314.6
for a substance listed or described as a border controlled precursor in that section;
the Minister may, under subsection (3), determine such a quantity of the drug, plant or precursor.
Note:
Sections
301.11
and
301.12
set out general rules for emergency determinations.
History
S 301.10 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 301.11 General rules
-
period of effect, publication etc.
(1)
A determination under this Subdivision has effect:
(a)
from the time it is registered (within the meaning of the
Legislative Instruments Act 2003
); and
(b)
for the period of 28 days from that registration or such shorter period as is specified in the determination.
(2)
However, despite paragraph (1)(b), if:
(a)
the Minister has made a determination under this Subdivision; and
(b)
exceptional circumstances have prevented the making of regulations to the same effect;
the Minister may, by legislative instrument, extend the period during which the determination is in force by no more than 28 days.
(3)
The Minister must not make more than one determination under sections
301.6
to
301.9
in relation to a particular substance or plant.
(4)
If the Minister makes a determination under this Subdivision, the Minister must, on or before the day on which the determination is registered:
(a)
make a public announcement of the determination; and
(b)
cause a copy of the announcement to be published:
(i)
on the internet; and
(ii)
in a newspaper circulating in each State, the Australian Capital Territory and the Northern Territory.
History
S 301.11(4) amended by No 8 of 2010, s 3 and Sch 5 item 137, by substituting
"
internet
"
for
"
Internet
"
(wherever occurring), effective 1 March 2010.
(5)
An announcement made under subsection (4) is not a legislative instrument.
History
S 301.11 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 301.12 General rule
-
inconsistency with regulations
301.12
Despite subsections
301.11(1)
and
(2)
, a determination made under this Subdivision has no effect to the extent that it is inconsistent with a regulation made under Subdivision
A
.
History
S 301.12 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
Div 301 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
Subdivision A
-
Serious drugs and precursors: definitions
History
Subdiv A substituted by No 167 of 2012, s 3 and Sch 1 item 16, applicable in relation to offences against Part
9.1
of the
Criminal Code
that are committed on or after 29 May 2013. For former wording and transitional provisions see note under Div
301
heading.
SECTION 301.9
Meaning of
drug analogue
(1)
A substance is a
drug analogue
of a listed controlled drug, or a listed border controlled drug, if the substance is any of the following in relation to the listed drug (or in relation to a primary analogue of the listed drug), however the substance is obtained:
(a)
one of the following (a
primary analogue
):
(i)
a stereoisomer;
(ii)
a structural isomer having the same constituent groups;
(iii)
an alkaloid;
(b)
(Repealed by No 15 of 2016)
(c)
a structural modification obtained in one or more of the following ways:
(i)
by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures;
(ii)
by the addition of hydrogen atoms to one or more unsaturated bonds;
(iii)
by the replacement of one or more of the groups or atoms specified in subsection
(2)
with one or more of the other groups or atoms specified in that subsection;
(iv)
by the conversion of a carboxyl or an ester group into an amide group;
(d)
any other homologue, analogue, chemical derivative or substance substantially similar in chemical structure.
Note:
Some substances are taken, for the purposes of this Part, to be drug analogues only in relation to particular offences against this Part, or particular elements of those offences: see subsection
301.4(3)
.
History
S 301.9(1) amended by No 98 of 2023, s 3 and Sch 2 items 13 and 14, by substituting
"
A
"
for
"
For the purposes of this Part, a
"
and inserting the note, effective 28 November 2023.
S 301.9(1) amended by No 15 of 2016, s 3 and Sch 3 items 1 and 2, by repealing para (b) and substituting para (c)(iii), effective 1 March 2016. Para (b) and (c)(iii) formerly read:
(b)
a structural modification obtained by the addition of one or more of the following groups:
(i)
alkoxy, cyclic diether, acyl, acyloxy, mono-amino or dialkylamino groups with up to 6 carbon atoms in any alkyl residue;
(ii)
alkyl, alkenyl or alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon;
(iii)
halogen, hydroxy, nitro or amino groups;
(c)(iii)
by the replacement of one or more of the groups specified in paragraph (b) with another such group or groups;
(2)
The following groups and atoms are specified:
(a)
alkoxy, cyclic diether, acyl, acyloxy, mono-amino or dialkylamino groups with up to 6 carbon atoms in any alkyl residue;
(b)
alkyl, alkenyl or alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon;
(c)
halogen, hydroxy, nitro or amino groups;
(d)
hydrogen atoms.
History
S 301.9(2) substituted by No 15 of 2016, s 3 and Sch 3 item 3, effective 1 March 2016. S 301.9(2) formerly read:
(2)
However, a
drug analogue
does not include a substance that is itself a listed controlled drug or a listed border controlled drug.
(3)
However:
(a)
a drug analogue of a listed controlled drug does not include a substance that is itself a listed controlled drug; and
(b)
a drug analogue of a listed border controlled drug does not include a substance that is itself a listed border controlled drug.
History
S 301.9(3) inserted by No 15 of 2016, s 3 and Sch 3 item 3, effective 1 March 2016.
(4)
In this section:
addition
has its ordinary meaning.
replacement
has its ordinary meaning.
History
S 301.9(4) inserted by No 15 of 2016, s 3 and Sch 3 item 3, effective 1 March 2016.
History
S 301.9 substituted by No 167 of 2012, s 3 and Sch 1 item 16, applicable in relation to offences against Part
9.1
of the
Criminal Code
that are committed on or after 29 May 2013. For former wording and transitional provisions see note under Div
301
heading.
View history note
Hide history note